A naukri.com initiative
Bioengineer
1w
97
Image Credit: Bioengineer
In Vivo Stem Cell Gene Therapy via Trafficking
- In vivo gene therapy utilizing lentiviral vectors has shown promise for treating early-onset genetic hematological and skeletal disorders by targeting hematopoietic stem and progenitor cells (HSPCs).
- Osteopetrosis, a rare genetic bone disease, results from mutations affecting osteoclast function, leading to dense and brittle bones and early bone marrow failure.
- The innovative approach focuses on delivering corrective genetic material to circulating HSPCs shortly after birth, bypassing the need for ex vivo stem cell manipulation.
- Experimental results indicate that in vivo gene therapy extends the survival of osteopetrotic neonatal mice by promoting the differentiation of gene-corrected HSPCs into functional osteoclasts.
- While complete phenotypic rescue remains a challenge, optimizing gene transfer efficiency and exploring combinatorial therapeutic strategies are crucial for treating severe genetic bone diseases.
- The research emphasizes the interplay between impaired osteoclastogenesis in osteopetrosis and disrupted HSPC homing to the bone marrow, offering insights for therapeutic targeting and understanding hematopoietic dynamics.
- The in vivo gene therapy approach postnatally mobilizes HSPCs into circulation, offering a less invasive and translatable intervention compared to conventional ex vivo methods.
- Phenotypic analyses demonstrate the ability of gene-corrected HSPCs to differentiate into functional osteoclasts within the bone marrow microenvironment, crucial for reversing the osteopetrotic bone phenotype.
- Challenges include the rapid disease progression in mouse models, warranting further research on enhancing vector tropism, transduction efficiency, and timing optimization for maximizing therapeutic benefits.
- The study's findings lay the groundwork for advancing postnatal gene therapy modalities targeting congenital disorders affecting hematopoietic and skeletal systems, offering new possibilities for clinical translation.
- Overall, this research highlights the potential of in vivo gene therapy early in life to address complex genetic disorders, paving the way for future clinical interventions and improving outcomes for patients with devastating genetic diseases.
Read Full Article
5 Likes
For uninterrupted reading, download the app